Jinyu Bio-Technology (600201.SH) issued an announcement that on June 24, 2024, the National Science and Technology Awards Conference for 2023 was held in Beijing. The project "Creation and Application of Recombinant Porcine Foot-and-mouth Disease Type 0 and A Bivalent Inactivated Vaccine" jointly submitted by the company's wholly-owned subsidiary JinYu Bao Ling Biopharmaceutical Co., Ltd. (hereinafter referred to as "JinYu Bao Ling") and Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences won the Second Prize of National Awards for Technological Invention in 2023. Zhao Lixia, General Manager of Jinyu Bao Ling, as the main person in charge of the project, won the Second Prize of National Technological Invention Award for this project.
Futu Securities News App: Jinyu Bio-Technology (600201.SH) issued an announcement that on June 24, 2024, the National Science and Technology Awards Conference for 2023 was held in Beijing. The project "Creation and Application of Recombinant Porcine Foot-and-mouth Disease Type 0 and A Bivalent Inactivated Vaccine" jointly submitted by the company's wholly-owned subsidiary JinYu Bao Ling Biopharmaceutical Co., Ltd. (hereinafter referred to as "JinYu Bao Ling") and Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences won the Second Prize of National Awards for Technological Invention in 2023. Zhao Lixia, General Manager of Jinyu Bao Ling, as the main person in charge of the project, won the Second Prize of National Technological Invention Award for this project.
Please use your Futubull account to access the feature.
This award fully affirms the company's scientific research achievements and innovation ability. The company will further promote the research and development of new animal vaccines and process improvement, and continue to improve the market competitiveness and brand influence of its products.